Disc Medicine Inc. (IRON)
NASDAQ · Healthcare
Disc Medicine Inc. EBITDA 2020–2025
Disc Medicine Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Disc Medicine Inc. ebitda for the quarter ending March 31, 2026 was -62.5 M, a 89.17% increase year-over-year.
- Disc Medicine Inc. ebitda for the twelve months ending March 31, 2026 was -237.4 M.
- Disc Medicine Inc. annual ebitda for 2025 was -207.9 M, a 92.05% increase from 2024.
- Disc Medicine Inc. annual ebitda for 2024 was -108.3 M, a 18.95% increase from 2023.
- Disc Medicine Inc. annual ebitda for 2023 was -91.0 M, a 92.34% increase from 2022.
- Disc Medicine Inc. annual ebitda for 2022 was -47.3 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Disc Medicine Inc. EBITDA — FAQ
Disc Medicine Inc. (IRON) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IRON's ebitda history?
The chart and table above show Disc Medicine Inc.'s ebitda by year and by quarter, including the growth rate.